Skip to main content

Advertisement

Table 1 :

From: Initial experience with topical fluorouracil (5-FU) for treatment of anal intraepithelial neoplasia (AIN) in HIV-positive patients

Age range in years (median) 32-67 (45)
On HAART (%) 9 (82%)
CD4+ cell count/┬ÁL range (median) 35-730 (416)
HIV viral copies/mL range (median) <75-172,966 (<75)
Treatment duration range (median) 7 wks-6 mo (20 wks)
Clinically improved (%) 6 (55%)
Perianal irritation (%) 8 (73%)
Anal fissure (%) 1 (9%)
Perianal HSV (%) 1 (9%)
Decreased dosing frequency (%) 6 (55%)
Discontinued (%) 1 (9%)